AGNES TONKUMOH: Open Payments
NPI 1891294906 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,750 in 135 payments from 47 companies in 2025. Trend: 2023 $427 · 2024 $2,308 · 2025 $3,750
Food & beverage: $3,490Education: $260
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $422 |
| PFIZER INC. | 6 | $229 |
| Pharmacosmos Therapeutics Inc. | 9 | $222 |
| ABBVIE INC. | 10 | $195 |
| Incyte Corporation | 4 | $195 |
| Regeneron Healthcare Solutions, Inc. | 4 | $184 |
| Merck Sharp & Dohme LLC | 8 | $179 |
| AstraZeneca Pharmaceuticals LP | 8 | $166 |
| GENZYME CORPORATION | 5 | $152 |
| Novartis Pharmaceuticals Corporation | 6 | $151 |
Products named: RYBREVANT, LIBTAYO, KEYTRUDA, Jakafi, PADCEV, ERLEADA, SARCLISA, EPKINLY.
Industry payments across OK — which companies pay providers there.
